Viking Systems retains Porter, LeVay & Rose to help communicate company's key initiatives

NewsGuard 100/100 Score

Viking Systems, Inc., a leading worldwide developer, manufacturer and marketer of 2D and 3D visualization solutions for complex minimally invasive surgery, today announced that it has retained Porter, LeVay & Rose, Inc., to advise the Company on its investor relations initiatives. Porter, LeVay & Rose, Inc. has more than forty years of experience in investor relations and financial public relations.

Jed Kennedy, President and CEO of Viking Systems, stated, "We are very excited to be working with Porter, LeVay & Rose to help communicate Viking's progress, results and key initiatives to the investment community. As we gain market adoption and penetration with our new 3DHD Visualization System, we look forward to sharing our progress with our shareholders and other members of the investment community. Porter, LeVay & Rose, with its extensive experience in the financial markets, will help us achieve our goals."

Michael Porter, President of Porter, LeVay & Rose, Inc., said, "We are excited about working with Viking Systems and its management team as we begin an active awareness and outreach program that will involve consistent communications and introductions to members of the investment community. Viking is involved in a very exciting industry, and with its recently released new technology, the Company is at a very interesting time in its evolution. We look forward to helping them achieve their objectives."

Source:

Viking Systems, Inc

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers identify increased brain tumor risk with specific contraceptive use